| Sickle cell anemia is an inherited form of anemia that occurs when the sickle cell gene is inherited from both parents. This results in an abnormality of the oxygen-carrying molecule (hemoglobin) in red blood cells (RBCs) that causes the normally round red blood cells to become deformed into a "sickle" shape. This sickle shape causes early destruction of the red blood cells (hemolysis), resulting in chronic anemia. It also causes the red blood cells to become trapped in small blood vessels, which blocks the circulation and causes severe pain and injury to many organs by interfering with their blood supply. Called sickle cell crisis, this problem occurs when the patient with sickle cell anemia experiences cellular oxygen deprivation. This might occur from overexertion, infection, high altitude, or cold.
The areas most often affected by the blocking action of sickle cells occur in the lungs, liver, bone, muscle, brain, spleen, penis, eyes, and kidneys. The clinical signs and symptoms of sickle cell anemia manifest early in life, usually after 6 months of age. There is no known cure.
Individuals with the sickle cell trait that are carriers of the sickle cell gene may only have symptoms under extreme conditions like low oxygen. If a carrier of the sickle cell trait has a child with another carrier, one-quarter of their children will have sickle cell anemia.Risk: Sickle cell anemia is seen most often in blacks, but may also be seen in those of Eastern Mediterranean, East Indian, and Saudi Arabian descent, and among Hispanics whose families originated in the Caribbean, Central America, or South America. The sickle cell gene is found in about 8% of blacks (Taher). Ironically, the high prevalence among these ethnic groups results from the protection the sickle cell gives against malaria. Sickle cell anemia is evenly distributed between the sexes. Incidence and Prevalence: About 1 in 500 blacks have sickle cell anemia; the prevalence is close to 1 in 2,000 for Hispanics whose families came from the Caribbean, Central America, or South America (Pegelow). Even though the sickle cell mutation began in India and Africa, it is now present throughout the world. |
Source: Medical Disability Advisor
| History: Individuals with sickle cell anemia manifest the features of chronic anemia, including pale skin and mucous membranes, fatigue, and decreased exercise capacity. They may also have a yellowing of their eyes and skin (jaundice), frequent infections, and poor wound healing. In addition, there are usually periodic episodes of severe pain in the joints, muscles, chest, or abdomen (sickle cell crisis). Episodes of constant erection of the penis (priapism) may occur in two-thirds of men with the condition, and symptoms of stroke are not uncommon (Embury 531).
There are three types of crisis: vaso-occlusive, hematologic, and infectious. Vaso-occlusive crisis is secondary to blood vessels being blocked by RBCs that are sickle shaped. This results in a decreased blood supply leading to pain of the joints and bodily organs such as the abdomen, muscles, skin, spleen, kidney, and brain; this can lead to ulcers, avascular necrosis, liver infarcts and papillary necrosis. Hematologic crisis happens if the spleen's outflow of blood is obstructed, leading to splenic sequestration of blood and splenic enlargement (splenomegaly). Malfunction of the spleen may also make individuals more susceptible to infections from encapsulated organisms such as Haemophilus influenzae type B (HIB), a highly contagious bacterium that causes meningitis, pneumonia, septic arthritis, and cellulitis. Another hematologic crisis, aplastic anemia, can occur when the bone marrow ceases making red blood cells. A poorly functioning immune system may result in infectious crisis. Physical exam: Physical findings may include a pale complexion (pallor), yellowing of the skin (jaundice), fever, elevated respiratory and heart rates, bleeding (hemorrhages) in the retina, and leg ulcers. The spleen is initially enlarged and then becomes abnormally small after repeated infarction (autoinfarction). A young child may appear small for his or her age, while an older child may experience delayed growth and puberty. The adult is usually thin with long extremities, narrow shoulders and hips, a curved spine, and a barrel chest. Individuals with splenic sequestration may have low blood pressure secondary to shock. They may also exhibit signs of congestive heart failure and neurologic deficits. Tests: A complete blood count (CBC) shows a marked anemia with low numbers of red blood cells, together with elevated numbers of white blood cells and platelets. A sickle prep test can demonstrate the sickle shape of the red blood cells. A specific blood test (hemoglobin electrophoresis) demonstrates the abnormal hemoglobin itself, called hemoglobin-S. If a stroke is suspected, a CT scan of the head is indicated for evaluation. A spinal tap is performed to evaluate for suspected meningitis. Peripheral smear can help in the visualization of blood cells. Arterial blood gas (ABG), electrocardiogram (ECG), chest x-ray (CXR), bone x-ray, bone scan, urinalysis, liver function tests (LFTs) and abdominal ultrasound may also be indicated. |
Source: Medical Disability Advisor
| There is no cure for sickle cell anemia, so management focuses on prevention and treatment of sickle crises and complications. Individuals are advised to avoid high altitudes and dehydration, treat infections promptly, and receive preventive vaccinations against pneumococcal pneumonia, Haemophilus influenzae type B, and meningococcus. Children should receive oral penicillin to reduce the incidence of infection and death from pneumococcal infection. For most individuals, the only daily treatment is folic acid supplements, but oral hydroxyurea is sometimes used regularly to reduce the frequency of crises. Treatment of acute crises often requires hospitalization and consists of rest, pain medications given by injection or through a vein (intravenous), intravenous fluids, oxygen, blood transfusions, and individualized treatments for any infections or complications. Genetic counseling is available for those contemplating pregnancy. Bone marrow transplants are currently the only potential cure for sickle cell anemia. In this treatment the patient's bone marrow (which makes the sickled red blood cells) is replaced with bone marrow from another individual without sickle cell disease. However, it is difficult to find the right bone marrow donor, and the drugs needed to make the transplant possible are highly toxic. |
Source: Medical Disability Advisor
| With the qualified exception of bone marrow transplant, there is no cure for sickle cell anemia, and life expectancy is reduced, with the median age of death being in the forties. Ongoing symptoms of anemia and repeated sickle cell crises can be expected, as can lasting problems caused by permanent organ damage. |
Source: Medical Disability Advisor
| Individuals with sickle cell anemia are at risk for damage to major organs because of poor circulation and sickle cell crises. Common complications include gallstones; damage to the spleen (autosplenectomy), with resultant susceptibility to serious infections; damage to the lungs (acute chest syndrome), bones (avascular necrosis), kidneys (papillary necrosis), and heart; strokes; and blindness over time (a result of impaired circulation to the retina and retinal bleeding). All these complications may occur or become worse during pregnancy. Approximately one-quarter of individuals with the condition have neurological complications such as stroke and transient ischemic attack (TIA) (Embury 527). |
Source: Medical Disability Advisor
| Chronic anemia can severely limit the individual's exercise tolerance and capacity for physical exertion. Additional restrictions and accommodations would depend on any long-term complications, such as decreased vision or blindness, physical limitations from strokes, respiratory problems, or chronic pain. Extra time off for treatment of sickle crises and infections can be expected. |
Source: Medical Disability Advisor
| If an individual fails to recover within the expected maximum duration period, the reader may wish to consider the following questions to better understand the specifics of an individual's medical case. Regarding diagnosis:
- Does individual show signs of chronic anemia, such as pale skin and mucous membranes, fatigue, and decreased exercise capacity?
-
Does individual have yellowing of the eyes and skin (jaundice)? Experience frequent infections? Do wounds heal poorly?
-
Have periodic episodes of severe pain in the joints, muscles, chest, or abdomen (sickle cell crisis) occurred?
-
Did an exam reveal elevated respiratory and heart rates? Bleeding (hemorrhages) in the retina? Leg ulcers?
-
Is spleen abnormally small over time (autoinfarction)?
-
Was a complete blood count (CBC) done? Did it show a marked anemia, with low numbers of red blood cells and elevated numbers of white blood cells and platelets?
-
Did a sickle prep test demonstrate sickle shape of the red blood cells?
-
Was a hemoglobin electrophoresis done? Was hemoglobin abnormal (hemoglobin-S)?
-
Were other chronic anemias, such as thalassemias or hemoglobin-SC disease, ruled out?
Regarding treatment:
- Since no cure is available for sickle cell anemia, was individual instructed in how to prevent and treat sickle cell crisis and complications?
-
Has individual avoided high altitudes?
-
Are infections being treated promptly?
-
Were preventative vaccinations against pneumococcal pneumonia, Haemophilus influenza type B, and meningococcus given?
-
Does individual take daily folic acid supplements? Oral hydroxyurea?
-
Was hospitalization required for acute crises?
Regarding prognosis:
- Has permanent organ damage occurred?
-
Have any complications developed, such as gallstones or damage to the spleen (autosplenectomy), lungs (acute chest syndrome), bones (avascular necrosis), kidneys (papillary necrosis), or heart?
-
Is individual pregnant? Was genetic counseling available?
|
Source: Medical Disability Advisor
| Embury, Stephen H., and Elliot P. Vichinsky. "Sickle Cell Disease." Hematology Basic Principles and Practice. Eds. David Hoffman, et al. 3rd ed. New York: Churchill Livingstone, Inc., 2000. MD Consult. Elsevier, Inc. 7 Jan. 2005 <http://home.mdconsult.com/das/book/43679376-6/view/1053?sid=328903190>.Pegelow, Charles. "Sickle Cell Anemia." eMedicine. Eds. Sharada A. Sarnaik, et al. 23 Jun. 2004. Medscape. 7 Jan. 2005 <http://emedicine.com/ped/topic2096.htm>. Taher, Ali, and Ziad Kazzi. "Anemia, Sickle Cell." eMedicine. Eds. Roy Alson, et al. 23 Jun. 2004. Medscape. 7 Jan. 2005 <http://emedicine.com/emerg/topic26.htm>. |
Source: Medical Disability Advisor
| Feedback |
| Send us comments, suggestions, corrections, or anything you would like us to hear. If you are not logged in, you must
include your email address, in order for us to respond. We cannot, unfortunately, respond to every comment.
If you are seeking medical advice, please contact your physician. Thank you! |
Send this comment to:
Sales
Customer Support
Content Development
|
|
| |
|
|
|
|
|
This publication is designed to provide accurate and authoritative information in
regard to the subject matter covered. It is published with the understanding that
the author, editors, and publisher are not engaged in rendering medical, legal,
accounting or other professional service. If medical, legal, or other expert assistance
is required, the service of a competent professional should be sought. We are unable to respond to requests for advice.
Any Sales inquiries should include an email address or other means of
communication.
|